{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:55:05Z","timestamp":1762102505294,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Big Health Inc.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Generalised anxiety disorder (GAD) is a chronic and disabling condition with considerable personal and economic impact. Cognitive behavioural therapy (CBT) is a recommended psychological therapy for GAD; however, there are substantial barriers to accessing treatment. Digital CBT, in particular smartphone-delivered CBT, has the potential to improve accessibility and increase dissemination of CBT. Despite the emerging evidence of smartphone-based psychological interventions for reducing anxiety, effect size scores are typically smaller than in-person interventions, and there is a lack of research assessing the efficacy of smartphone-delivered digital interventions specifically for GAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In the DeLTA trial (DigitaL Therapy for Anxiety), we plan to conduct a parallel-group superiority randomised controlled trial examining the efficacy of a novel smartphone-based digital CBT intervention for GAD compared to a waitlist control. We aim to recruit 242 adults (aged 18 years or above) with moderate-to-severe symptoms of GAD. This trial will be conducted entirely online and will involve assessments at baseline (week 0; immediately preceding randomisation), mid-intervention (week 3), post-intervention (week 6; primary end point) and follow-up (week 10). The primary objective is to evaluate the efficacy of the intervention on GAD symptom severity compared to a waitlist control at post-intervention. Secondary objectives are to examine between-group effects on GAD at follow-up, and to examine the following secondary outcomes at both post-intervention and follow-up: 1) worry; 2) depressive symptoms; 3) wellbeing; 4) quality of life; and 5) sleep difficulty.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This trial will report findings on the initial efficacy of a novel digital CBT intervention for GAD. Results have the potential to contribute towards the evidence base for digital CBT for GAD and increase the dissemination of CBT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ISRCTN, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.isrctn.com\/ISRCTN12765810\">ISRCTN12765810<\/jats:ext-link>. Registered on 11 January 2019.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-020-4230-6","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T17:03:32Z","timestamp":1587661412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of digital cognitive behavioural therapy for symptoms of generalised anxiety disorder: a study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"21","author":[{"given":"J.","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2936-7717","authenticated-orcid":false,"given":"C. B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Espie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Stott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Emsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A. J.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Craske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. E. A.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Carl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"issue":"6","key":"4230_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2005;62(6):593 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15939837.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"4230_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","volume":"146","author":"K Kroenke","year":"2007","unstructured":"Kroenke K, Spitzer RL, Williams JBW, Monahan PO, L\u00f6we B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317\u201325.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"4230_CR3","first-page":"20","volume":"65","author":"PP Roy-Byrne","year":"2004","unstructured":"Roy-Byrne PP, Wagner A. Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry. 2004;65(Suppl 1):20\u20136.","journal-title":"J Clin Psychiatry"},{"key":"4230_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1192\/bjp.176.6.544","volume":"176","author":"KA Yonkers","year":"2000","unstructured":"Yonkers KA, Dyck IR, Warshaw M, Keller MB. Factors predicting the clinical course of generalised anxiety disorder. Br J Psychiatry. 2000;176:544\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10974960.","journal-title":"Br J Psychiatry"},{"key":"4230_CR5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Washington, DC: American Psychiatric Asscociation; 2013.","edition":"5"},{"issue":"Suppl 1","key":"4230_CR6","first-page":"4","volume":"63","author":"J-P L\u00e9pine","year":"2002","unstructured":"L\u00e9pine J-P. The epidemiology of anxiety disorders: prevalence and societal costs. J Clin Psychiatry. 2002;63(Suppl 1):4\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"4230_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jad.2011.11.014","volume":"140","author":"DA Revicki","year":"2012","unstructured":"Revicki DA, Travers K, Wyrwich KW, Sveds\u00e4ter H, Locklear J, Mattera MS, et al. Humanistic and economic burden of generalized anxiety disorder in North America and Europe. J Affect Disord. 2012;140(2):103\u201312 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22154706.","journal-title":"J Affect Disord"},{"issue":"4","key":"4230_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/da.10065","volume":"16","author":"H-U Wittchen","year":"2002","unstructured":"Wittchen H-U. Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety. 2002;16(4):162\u201371.","journal-title":"Depress Anxiety"},{"key":"4230_CR9","volume-title":"Clinical practice review for GAD","author":"Anxiety and Depression Association of America","year":"2015","unstructured":"Anxiety and Depression Association of America. Clinical practice review for GAD. 2015. Available from: https:\/\/adaa.org\/resources-professionals\/practice-guidelines-gad."},{"key":"4230_CR10","volume-title":"Diagnosis and management of generalized anxiety disorder and panic disorder in adults","author":"AB Locke","year":"2015","unstructured":"Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults, vol. 91; 2015."},{"key":"4230_CR11","volume-title":"Clinical Guideline [CG113] Generalised anxiety disorder and panic disorder in adults: management","author":"National Institute for Health and Clinical Excellence","year":"2011","unstructured":"National Institute for Health and Clinical Excellence. Clinical Guideline [CG113] Generalised anxiety disorder and panic disorder in adults: management. 2011."},{"issue":"8 Suppl 2","key":"4230_CR12","first-page":"9S","volume":"51","author":"Canadian Psychiatric Association","year":"2006","unstructured":"Canadian Psychiatric Association. Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry. 2006;51(8 Suppl 2):9S\u201391S.","journal-title":"Can J Psychiatry"},{"key":"4230_CR13","volume-title":"Exercise for mood and anxiety disorders","author":"M Otto","year":"2009","unstructured":"Otto M, Smits J. Exercise for mood and anxiety disorders. New York: Oxford University Press; 2009."},{"key":"4230_CR14","volume-title":"The complete CBT guide for anxiety","author":"R Shafran","year":"2013","unstructured":"Shafran R, Brosan L, Cooper P. The complete CBT guide for anxiety. London: Constable & Robinson; 2013."},{"key":"4230_CR15","volume-title":"Mastery of your anxiety and worry","author":"R Zinbarg","year":"2006","unstructured":"Zinbarg R, Craske M, Barlow D. Mastery of your anxiety and worry. 2nd ed. Oxford: Oxford University Press; 2006.","edition":"2"},{"issue":"6","key":"4230_CR16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/da.22728","volume":"35","author":"JK Carpenter","year":"2018","unstructured":"Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JAJ, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;35(6):502\u201314.","journal-title":"Depress Anxiety"},{"issue":"2","key":"4230_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cpr.2014.01.002","volume":"34","author":"P Cuijpers","year":"2014","unstructured":"Cuijpers P, Sijbrandij M, Koole S, Huibers M, Berking M, Andersson G. Psychological treatment of generalized anxiety disorder: a meta-analysis. Clin Psychol Rev. 2014;34(2):130\u201340 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24487344.","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"4230_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0033582","volume":"69","author":"JS Comer","year":"2014","unstructured":"Comer JS, Barlow DH. The occasional case against broad dissemination and implementation: retaining a role for specialty care in the delivery of psychological treatments. Am Psychol. 2014;69(1):1\u201318 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23915401.","journal-title":"Am Psychol"},{"issue":"2","key":"4230_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.cpr.2009.11.001","volume":"30","author":"RW Gunter","year":"2010","unstructured":"Gunter RW, Whittal ML. Dissemination of cognitive-behavioral treatments for anxiety disorders: overcoming barriers and improving patient access. Clin Psychol Rev. 2010;30(2):194\u2013202 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272735809001561.","journal-title":"Clin Psychol Rev"},{"issue":"2","key":"4230_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s40675-017-0065-4","volume":"3","author":"AI Luik","year":"2017","unstructured":"Luik AI, Kyle SD, Espie CA. Digital cognitive behavioral therapy (dCBT) for insomnia: a state-of-the-science review. Curr Sleep Med Rep. 2017;3(2):48\u201356 Available from: http:\/\/link.springer.com\/10.1007\/s40675-017-0065-4.","journal-title":"Curr Sleep Med Rep"},{"issue":"10","key":"4230_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S2215-0366(17)30333-4","volume":"4","author":"D Bhugra","year":"2017","unstructured":"Bhugra D, Tasman A, Pathare S, Priebe S, Smith S, Torous J, et al. The WPA- Lancet Psychiatry Commission on the future of psychiatry. Lancet Psychiatry. 2017;4(10):775\u2013818.","journal-title":"Lancet Psychiatry"},{"key":"4230_CR22","unstructured":"Hedman E, Andersson E, Lj\u00f3tsson B, Andersson G, R\u00fcck C, Lindefors N. Cost-effectiveness of internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: results from a randomized controlled trial. Available from: http:\/\/www.random.org. Cited 16 Aug 2018."},{"issue":"1","key":"4230_CR23","doi-asserted-by":"publisher","first-page":"e0190554","DOI":"10.1371\/journal.pone.0190554","volume":"13","author":"S Kumar","year":"2018","unstructured":"Kumar S, Jones Bell M, Juusola JL. Mobile and traditional cognitive behavioral therapy programs for generalized anxiety disorder: a cost-effectiveness analysis. PLoS One. 2018;13(1):e0190554 Seedat S, editor. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0190554.","journal-title":"PLoS One"},{"issue":"1","key":"4230_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41746-018-0021-9","volume":"1","author":"O Byambasuren","year":"2018","unstructured":"Byambasuren O, Sanders S, Beller E, Glasziou P. Prescribable mHealth apps identified from an overview of systematic reviews. NPJ Digit Med. 2018;1(1):12 Available from: http:\/\/www.nature.com\/articles\/s41746-018-0021-9.","journal-title":"NPJ Digit Med"},{"issue":"6","key":"4230_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11920-018-0910-2","volume":"20","author":"J Firth","year":"2018","unstructured":"Firth J, Torous J, Carney R, Newby J, Cosco TD, Christensen H, et al. Digital technologies in the treatment of anxiety: recent innovations and future directions. Curr Psychiatry Rep. 2018;20(6):44 Available from: http:\/\/link.springer.com\/10.1007\/s11920-018-0910-2.","journal-title":"Curr Psychiatry Rep"},{"key":"4230_CR26","unstructured":"Pew Research Center. Demographics of mobile device ownership and adoption in the United States: Pew Research Center; 2019. Available from: https:\/\/www.pewinternet.org\/fact-sheet\/mobile\/."},{"issue":"2","key":"4230_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/schbul\/sbv132","volume":"42","author":"J Firth","year":"2016","unstructured":"Firth J, Cotter J, Torous J, Bucci S, Firth JA, Yung AR. Mobile phone ownership and endorsement of health among people with psychosis: a meta-analysis of cross-sectional studies. Schizophr Bull. 2016;42(2):448\u201355 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26400871.","journal-title":"Schizophr Bull"},{"key":"4230_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jad.2017.04.046","volume":"218","author":"J Firth","year":"2017","unstructured":"Firth J, Torous J, Nicholas J, Carney R, Rosenbaum S, Sarris J. Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord. 2017;218:15\u201322 Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0165032717300150.","journal-title":"J Affect Disord"},{"issue":"3","key":"4230_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/wps.20673","volume":"18","author":"J Linardon","year":"2019","unstructured":"Linardon J, Cuijpers P, Carlbring P, Messer M, Fuller-Tyszkiewicz M. The efficacy of app-supported smartphone interventions for mental health problems: a meta-analysis of randomized controlled trials. World Psychiatry. 2019;18(3):325\u201336 Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/wps.20673.","journal-title":"World Psychiatry"},{"key":"4230_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S2215-0366(17)30153-0","volume":"4","author":"SM Gold","year":"2017","unstructured":"Gold SM, Enck P, Hasselmann H, Friede T, Hegerl U, Mohr DC, et al. Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry. 2017;4:725\u201332 Elsevier Ltd.","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"4230_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17695343.","journal-title":"Behav Res Methods"},{"issue":"2","key":"4230_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s10608-014-9606-z","volume":"38","author":"PM Enock","year":"2014","unstructured":"Enock PM, Hofmann SG, McNally RJ. Attention bias modification training via smartphone to reduce social anxiety: a randomized, controlled multi-session experiment. Cognit Ther Res. 2014;38(2):200\u201316 Available from: http:\/\/link.springer.com\/10.1007\/s10608-014-9606-z.","journal-title":"Cognit Ther Res"},{"key":"4230_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.janxdis.2016.09.012","volume":"44","author":"E Ivanova","year":"2016","unstructured":"Ivanova E, Lindner P, Ly KH, Dahlin M, Vernmark K, Andersson G, et al. Guided and unguided acceptance and commitment therapy for social anxiety disorder and\/or panic disorder provided via the Internet and a smartphone application: a randomized controlled trial. J Anxiety Disord. 2016;44:27\u201335 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27721123.","journal-title":"J Anxiety Disord"},{"issue":"1","key":"4230_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/g4h.2015.0033","volume":"5","author":"Q Pham","year":"2016","unstructured":"Pham Q, Khatib Y, Stansfeld S, Fox S, Green T. Feasibility and efficacy of an mHealth game for managing anxiety: \u201cflowy\u201d randomized controlled pilot trial and design evaluation. Games Health J. 2016;5(1):50\u201367 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26536488.","journal-title":"Games Health J"},{"issue":"10","key":"4230_CR35","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006;166(10):1092.","journal-title":"Arch Intern Med"},{"key":"4230_CR36","volume-title":"Mini international neuropsychiatric interview 7.0","author":"D Sheehan","year":"2014","unstructured":"Sheehan D. Mini international neuropsychiatric interview 7.0. Jacksonville: Medical Outcomes Systems; 2014."},{"key":"4230_CR37","unstructured":"Qualtrics. Qualtrics. Provo; 2019. Available from: http:\/\/www.qualtrics.com."},{"issue":"1","key":"4230_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18 Available from: http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-8-18.","journal-title":"BMC Med"},{"key":"4230_CR39","unstructured":"First MB, Williams JBW, Karg RS, Spitzer RL. SCID-5-RV: structured clinical interview for DSM-5 disorders, research version: American Psychiatric Association; 2015. p. 95. Available from: https:\/\/www.appi.org\/Structured_Clinical_Interview_for_DSM-5_Disorders-Clinician_Version_SCID-5-CV."},{"issue":"1\u20132","key":"4230_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jad.2011.03.024","volume":"133","author":"D Richards","year":"2011","unstructured":"Richards D, Borglin G. Implementation of psychological therapies for anxiety and depression in routine practice: two year prospective cohort study. J Affect Disord. 2011;133(1\u20132):51\u201360.","journal-title":"J Affect Disord"},{"issue":"6","key":"4230_CR41","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0005-7967(90)90135-6","volume":"28","author":"TJ Meyer","year":"1990","unstructured":"Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the penn state worry questionnaire. Behav Res Ther. 1990;28(6):487\u201395 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0005796790901356.","journal-title":"Behav Res Ther"},{"issue":"1","key":"4230_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0005-7967(92)90093-V","volume":"30","author":"TA Brown","year":"1992","unstructured":"Brown TA, Antony MM, Barlow DH. Psychometric properties of the Penn State Worry Questionnaire in a clinical anxiety disorders sample. Behav Res Ther. 1992;30(1):33\u20137 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1540110.","journal-title":"Behav Res Ther"},{"issue":"9","key":"4230_CR43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11556941.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"4230_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","volume":"32","author":"K Kroenke","year":"2010","unstructured":"Kroenke K, Spitzer RL, Williams JBW, L\u00f6we B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345\u201359.","journal-title":"Gen Hosp Psychiatry"},{"key":"4230_CR45","volume-title":"The improving access to psychological therapies manual appendices and helpful resources","author":"National Collaborating Centre for Mental Health","year":"2018","unstructured":"National Collaborating Centre for Mental Health. The improving access to psychological therapies manual appendices and helpful resources. 2018."},{"issue":"3","key":"4230_CR46","doi-asserted-by":"publisher","first-page":"e004183","DOI":"10.1136\/bmjopen-2013-004183","volume":"4","author":"CA Espie","year":"2014","unstructured":"Espie CA, Kyle SD, Hames P, Gardani M, Fleming L, Cape J. The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder. BMJ Open. 2014;4(3):e004183 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24643168.","journal-title":"BMJ Open"},{"issue":"1","key":"4230_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1477-7525-5-63","volume":"5","author":"R Tennant","year":"2007","unstructured":"Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5(1):63 Available from: http:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-5-63.","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"4230_CR48","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/00005650-199411000-00004","volume":"32","author":"DA Ruta","year":"1994","unstructured":"Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care. 1994;32(11):1109\u201326 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7967852.","journal-title":"Med Care"},{"issue":"4","key":"4230_CR49","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11136-006-9152-6","volume":"16","author":"F Martin","year":"2007","unstructured":"Martin F, Camfield L, Rodham K, Kliempt P, Ruta D. Twelve years\u2013experience with the Patient Generated Index (PGI) of quality of life: a graded structured review. Qual Life Res. 2007;16(4):705\u201315 Available from: http:\/\/link.springer.com\/10.1007\/s11136-006-9152-6.","journal-title":"Qual Life Res"},{"issue":"2","key":"4230_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0005-7916(00)00012-4","volume":"31","author":"GJ Devilly","year":"2000","unstructured":"Devilly GJ, Borkovec TD. Psychometric properties of the credibility\/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000;31(2):73\u201386.","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"8","key":"4230_CR51","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.sleep.2011.03.016","volume":"12","author":"SD Kyle","year":"2011","unstructured":"Kyle SD, Morgan K, Spiegelhalder K, Espie CA. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med. 2011;12(8):735\u201347 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21907616.","journal-title":"Sleep Med"},{"key":"4230_CR52","volume-title":"Stata statistical software: release 15","author":"StataCorp","year":"2017","unstructured":"StataCorp. Stata statistical software: release 15. College Station: StataCorp LLC; 2017."},{"key":"4230_CR53","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137 American College of Physicians.","journal-title":"Ann Intern Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-020-4230-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T23:34:24Z","timestamp":1619134464000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-4230-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4230"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-4230-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"7 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been granted ethical approval by the University of Oxford Central University Research Ethics Committee (CUREC; reference number R61262\/RE002). Informed consent will be obtained from all participants through completion of an online consent form. Important modifications to the trial protocol will be submitted for approval from the trial sponsor (University of Oxford; ) and CUREC.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CAE is co-founder and Chief Medical Officer of Big Health Inc., and is a shareholder in the company. CBM, ALH, RS, MLD and JC are employed by Big Health Inc., and are salaried by the company. JG previously received a salary from Big Health Inc. JAJS is a paid Clinical Advisor for Big Health Inc., and receives royalty payments from Oxford University Press and Academic Press. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"357"}}